These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study. Dieckmann KP, Radtke A, Geczi L, Matthies C, Anheuser P, Eckardt U, Sommer J, Zengerling F, Trenti E, Pichler R, Belz H, Zastrow S, Winter A, Melchior S, Hammel J, Kranz J, Bolten M, Krege S, Haben B, Loidl W, Ruf CG, Heinzelbecker J, Heidenreich A, Cremers JF, Oing C, Hermanns T, Fankhauser CD, Gillessen S, Reichegger H, Cathomas R, Pichler M, Hentrich M, Eredics K, Lorch A, Wülfing C, Peine S, Wosniok W, Bokemeyer C, Belge G. J Clin Oncol; 2019 Jun 01; 37(16):1412-1423. PubMed ID: 30875280 [Abstract] [Full Text] [Related]
3. Can germ cell neoplasia in situ be diagnosed by measuring serum levels of microRNA371a-3p? Radtke A, Cremers JF, Kliesch S, Riek S, Junker K, Mohamed SA, Anheuser P, Belge G, Dieckmann KP. J Cancer Res Clin Oncol; 2017 Nov 01; 143(11):2383-2392. PubMed ID: 28819887 [Abstract] [Full Text] [Related]
5. Circulating MicroRNAs for Detection of Germ Cell Tumours: A Narrative Review. Fankhauser CD, Nuño MM, Murray MJ, Frazier L, Bagrodia A. Eur Urol Focus; 2022 May 01; 8(3):660-662. PubMed ID: 35537936 [Abstract] [Full Text] [Related]
6. MicroRNA miR-371a-3p in serum of patients with germ cell tumours: evaluations for establishing a serum biomarker. Spiekermann M, Belge G, Winter N, Ikogho R, Balks T, Bullerdiek J, Dieckmann KP. Andrology; 2015 Jan 01; 3(1):78-84. PubMed ID: 25187505 [Abstract] [Full Text] [Related]
7. Serum Levels of MicroRNA371a-3p: A Highly Sensitive Tool for Diagnosing and Staging Testicular Germ Cell Tumours: A Clinical Case Series. Anheuser P, Radtke A, Wülfing C, Kranz J, Belge G, Dieckmann KP. Urol Int; 2017 Jan 01; 99(1):98-103. PubMed ID: 28586780 [Abstract] [Full Text] [Related]
8. Evaluation of miR-371a-3p to predict viable germ cell tumor in patients with pure seminoma receiving retroperitoneal lymph node dissection. Konneh B, Lafin JT, Howard J, Gerald T, Amini A, Savelyeva A, Woldu SL, Lewis CM, Jia L, Margulis V, Coleman N, Scarpini C, Frazier AL, Murray MJ, Amatruda JF, Bagrodia A. Andrology; 2023 May 01; 11(4):634-640. PubMed ID: 36254623 [Abstract] [Full Text] [Related]
9. microRNA-371a-3p as informative biomarker for the follow-up of testicular germ cell cancer patients. van Agthoven T, Eijkenboom WMH, Looijenga LHJ. Cell Oncol (Dordr); 2017 Aug 01; 40(4):379-388. PubMed ID: 28612337 [Abstract] [Full Text] [Related]